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Fibronectin Growth Factor-Binding Domains
Are Required for Fibroblast Survival
Fubao Lin1, Xiang-Dong Ren2, Zhi Pan3, Lauren Macri1, Wei-Xing Zong4, Marcia G. Tonnesen2,5,
Miriam Rafailovich3, Dafna Bar-Sagi6 and Richard A.F. Clark1,2
Fibronectin (FN) is required for embryogenesis, morphogenesis, and wound repair, and its Arg–Gly–Asp-
containing central cell-binding domain (CCBD) is essential for mesenchymal cell survival and growth. Here, we
demonstrate that FN contains three growth factor-binding domains (FN-GFBDs) that bind platelet-derived
growth factor-BB (PDGF-BB), a potent fibroblast survival and mitogenic factor. These sites bind PDGF-BB with
dissociation constants of 10–100 nM. FN-null cells cultured on recombinant CCBD (FNIII811) without a FN-GFBD
demonstrated minimal metabolism and underwent autophagy at 24 hours, followed by apoptosis at 72 hours,
even in the presence of PDGF-BB. In contrast, FN-null cells plated on FNIII811 contiguous with FN-GFBD
survived without, and proliferated with, PDGF-BB. FN-null cell survival on FNIII811 and noncontiguous arrays of
FN-GFBDs required these domains to be adsorbed on the same surface, suggesting the existence of a
mesenchymal cell-extracellular matrix synapse. Thus, fibroblast survival required GF stimulation in the presence
of a FN-GFBD, as well as adhesion to FN through the CCBD. The findings that fibroblast survival is dependent
on FN-GFBD underscore the critical importance of pericellular matrix for cell survival and have significant
implications for cutaneous wound healing and regeneration.
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INTRODUCTION
Fibroblasts are responsible for connective tissue formation,
homeostasis, and repair, and thereby for the overall archi-
tecture of many organs. During cutaneous wound healing,
fibroblast ingrowth is the rate-limiting step in new connective
tissue production (McClain et al., 1996). Injury progression
and failure to heal are associated with fibroblast dysfunction,
often leading to apoptosis (Clark, 2008a). A better under-
standing of the requirements for fibroblast survival and
growth under both normal and pathological conditions
would facilitate the design of new therapies for cutaneous
wound healing. Fibronectin (FN) and platelet-derived growth
factor-BB (PDGF-BB) have been identified as two major
survival factors for fibroblasts (Zhang et al., 1995; Ilic et al.,
1998; Romashkova and Makarov, 1999), but whether there is
interdependency between these fibroblast survival factors has
not been addressed.
FN is a 500-kDa multidomain, multifunctional cell
adhesion glycoprotein (Figure 1a) found in blood and
deposited with fibrin in wounds as a provisional matrix
(Yamada and Clark, 1996; Pankov and Yamada, 2002).
Additional FN, derived from wound fibroblasts and other
local tissue cells, appears in concert with reepithelialization
and granulation tissue formation (Clark et al., 1983). As
FN ablation is embryonically lethal (George et al., 1993), no
definitive studies have been performed to demonstrate the
requirement of FN during cutaneous injury. However, as the
brain lacks macrophages and fibroblasts, and thus cannot
produce local FN, Sakai et al. (2001) ablated hepatic FN in a
mouse and determined that plasma FN supports neuronal
survival and reduces brain injury. Importantly, chronic
nonhealing cutaneous wounds and burns demonstrate an
absence of FN in the wound bed (Grinnell and Zhu, 1994;
Herrick et al., 1996). That FN may be required for wound
healing comes from several lines of evidence: FN promotes
fibroblast survival (Zhang et al., 1995; Ilic et al., 1998),
proliferation (Renshaw et al., 1997), and migration through
three-dimensional extracellular matrix (ECM) (Greiling and
Clark, 1997). These activities require fibroblast attachment to
FN at the Arg–Gly–Asp (RGD) sequence in the tenth FN type
III repeat (see numbered rectangles in Figure 1a) through cell
surface membrane integrin receptors (Ruoslahti, 1991). Of all
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integrins, a5b1 mediates the strongest binding to FN, as well
as fibroblast survival signals (Zhang et al., 1995). Optimal
a5b1-binding activity requires a synergy site that includes
the Pro–His–Ser–Arg–Asn sequence in the ninth FN type III
repeat (Aota et al., 1994; Redick et al., 2000), as well as the
RGD peptide in the tenth FN type III repeat (Pierschbacher
and Ruoslahti, 1987). Thus, together the ninth and tenth FN
type III repeats compose the critical core of the FN-central
cell-binding domain (CCBD) (Redick et al., 2000; Feng and
Mrksich, 2004). Although the ninth and tenth FN type III
repeats when expressed as a recombinant protein are
conformationally unstable (Litvinovich et al., 1998), flanking
the core with FN ninth and eleventh type III repeats confers
stability.
PDGFs are major mitogens and survival factors for many
mesenchymal cell types including fibroblasts (Romashkova
and Makarov, 1999). PDGF occurs as five isoforms: classic
PDGF-AA, AB, and BB isoforms, and more recently described
PDGF-CC and PDGF-DD isoforms (Fredriksson et al., 2004).
The most potent isoforms, PDGF-AB and -BB, are secreted by
platelets (PDGF-AB), macrophages (PDGF-BB), and epider-
mal cells (PDGF-BB) in response to injury. PDGFB knockout
mice are invariably embryonically lethal, whereas loss of
other isoforms is not lethal (Betsholtz, 2004).
In fibroblasts, FN and growth factor (GF) signals converge
at the level of the focal contact (Plopper et al., 1995) and are
costimulatory (Miyamoto et al., 1996) for progression through
the cell cycle (Assoian and Schwartz, 2001). Here, we
demonstrate for the first time that FN and PDGF-BB survival
signals for fibroblasts require FN-growth factor-binding
domains (FN-GFBDs) and we map the operational sites. We
believe that the FN-GFBDs delineated here have a potential
use in therapies that facilitate and accelerate wound healing
and possibly induce tissue regeneration.
RESULTS
FN-bound PDGF-BB
PDGF-BB associated with human plasma FN when it was
incubated with reduced FN monomers that were attached
to SulfoLink Beads (Pierce, Rockford, IL) (Figure 1b). To
determine the site(s) of this association, three large fragments
of the human plasma FN molecule that span from its amino-
terminus through the fifteenth type III repeat were tested
(Figure 1a). PDGF-BB had no affinity for the FN 70-kDa
terminal fragment (FN70), which includes the fibrin and the
collagen/gelatin-binding domains, and is critical for FN
fibrillogenesis (Mao and Schwarzbauer, 2005) (Figure 1c).
In contrast, PDGF-BB associated with FN domains consisting
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Figure 1. Platelet-derived growth factor-BB (PDGF-BB) association with intact fibronectin (FN), FN 70-kDa terminal fragment (FN70), and fibronectin
type III repeats: FNIII111 and FNIII8v15. (a) Schematic of human plasma FN. FN type I repeats are shown as thin rectangles, FN type II repeats as ovals,
and FN type III repeats as large rectangles. The large functional domains of FN assayed for PDGF-BB binding are noted by brackets above and below the
schematic. The Arg–Gly–Asp (RGD)-containing (arrow) FN-central cell-binding domain (CCBD) (FNIII811) is indicated by the bracket between the two chains of
FN. V indicates the entire 120-kDa FN variable domain that is also called IIICS. (b–e) Intact human plasma FN, FN70, or an extended type III repeat domain
(either FNIII111 or FNIII8v15) was adsorbed to plastic tissue culture dishes at 0.125 mM, and then incubated with
125I-radiolabeled PDGF-BB in DMEM
containing 1% BSA for 90minutes at room temperature. After thorough washing, radioactivity of bound PDGF-BB was determined by a g-counter. (b) PDGF-BB
association with intact human plasma FN. (c) Lack of PDGF-BB association with FN70 fragment. (d) PDGF-BB association with FNIII111. (e) PDGF-BB
association with FNIII8v15. Figures are representative of at least three independent experiments. CPM, counts per minute.
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of the FN-CCBD and either the amino- or carboxy-terminal
thirds of FN type III repeats (FNIII111 and FNIII8v15)
(Figure 1d and e). To confirm and expand these results,
additional recombinant FN domains were cloned and
expressed as previously described (Wang et al., 2005)
and assayed by plasmon surface resonance to determine
dissociation constants (KDs) (Figure 2, Table 1).
As determined by plasmon surface resonance, PDGF-BB
bound FN recombinant domains that included FNIII1,
FNIII1314, or the entire FN variable domain (V) with KDs
of 103, 9, and 141nM, respectively (Figure 2, Table 1). In
contrast, PDGF-BB did not bind FN120—a chymotrypic
fragment of FN (Ginsberg et al., 1985) that contained the
second to eleventh FN type III repeats as determined by QStar
pulser (Applied Biosystems, Foster City, CA) quadrupole
time-of-flight mass spectroscopy sequencing—FNIII36, or
the FN-CCBD (FNIII811) (Figure 2, Table 1). Importantly,
PDGF-BB binding did not demonstrate any diminution when
up to 2.5 M NaCl was added or when the pH was lowered to
2, indicating that electrostatic charge was not important for
the interactions (data not shown).
FN-CCBD was not sufficient for FN-null cell survival
FN is secreted and deposited in the pericellular matrix by all
mesenchymal cells (Mosher, 1995). Therefore, it was
necessary to perform survival studies with mouse FN-null
fibroblasts (Saoncella et al., 1999). When these cells were
plated on intact FN in the absence of serum or exogenous
GFs, they survived for 5 days, and proliferated in response to
a single dose of 30 ngml–1 PDGF-BB (Figure 3a). In contrast,
FN-null cells failed to proliferate or even survive in the
presence of exogenous PDGF-BB when plated on the FN
central cell-binding domain (FNIII811) fused to glutathione
S-transferase (GST) to improve surface adsorption as pre-
viously described (Wang et al., 2005). FNIII811, not fused
with GST, also failed to support FN-null cell survival (data not
shown). Remarkably, contiguous constructs of the CCBD
with all type III repeats on its amino terminal side (FNIII111)
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Figure 2. Platelet-derived growth factor-BB (PDGF-BB)-bound fibronectin (FN) recombinant domains that included fibronectin type III repeats: FNIII1,
FNIII1314, or fibronectin variable domain (V). Real-time interaction of PDGF-BB with FN domains was determined by plasmon surface resonance (BiaCore
2000). FN domains were injected (6.25–200 nM, 30mlminute–1) across a biosensor chip to which PDGF-BB had been conjugated. Chip cell without PDGF-BB
was used as a reference. Sensorgrams are representative of three different experiments. Dissociation constants (KDs) were derived from the ratio of kinetic
dissociation constants (kd) divided by kinetic association constants (ka). RU, resonance unit.
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or with all type III repeats on its carboxy-terminal side
(FNIII8V15) supported FN-null cell survival and proliferation
equivalent to intact FN (Figure 3a). Increasing GST-FNIII811
concentration to 5-fold in these studies improved survival
marginally at 3 days (Figure 3b) and not appreciably at 5 days
(data not shown). Furthermore, FN120 (FNIII211) also failed
to sustain FN-null cell survival (Figure 3c). Supraphysiologi-
cal concentrations of PDGF-BB, up to 300 ngml–1, which is
410-fold higher than normal serum levels (Heldin and
Westermark, 1999), failed to improve survival when cells
were cultured on GST-FNIII811 (Figure 3d). Endogenous
PDGF appeared to contribute little, if any, to these results as
FN-null cells produced only 0.34 ng PDGF-AA per 106 cells
and 0.28 ng PDGF-BB per 106 cells over a 48-hour period as
judged by ELISA. Addition of 30 ngml–1 PDGF-BB repeatedly
at 4, 8 and 24 hours (Jones and Kazlauskas, 2001) also
failed to promote survival (data not shown). The difference
in cell survival was not attributable to differential attachment,
as numbers of FN-null cells that attached to GST-FNIII811
were indistinguishable from the numbers of cells that
attached to intact FN, FNIII111, or FNIII8v15 after 4 hours
(data not shown). Furthermore, FN-GFBDs do not interact
with fibroblast surface membranes in the absence of PDGF-
BB as judged by confocal spectroscopy (data not shown).
Thus, FN-null cells failed to survive on GST-FNIII811
that had been preadsorbed at any concentration tested even
when the cells were cultured in the presence of exogenous
PDGF-BB.
Initial spreading and FA formation did not require FN-GFBDs
Previously, we reported that GST-tagged CCBD (FNIII811),
unlike FNIII811 without GST, appeared similar to intact FN
in its support of fibroblast spreading, actin stress fiber
assembly, and focal adhesion (FA) formation for as long as
2 hours, using both adult human dermal fibroblasts and
mouse FN-null cells (Wang et al., 2005). Here, we extend
the observations on FN-null cell responses to intact FN for
time periods from 4 to 72 hours and responses to domains of
FN that include the GST-tagged central cell-binding domain
(GST-FNIII811) in context of a FN-GFBD (FNIII111 or
FNIII8V15) for the same time periods. FN-null cells plated
on GST-FNIII811 displayed vinculin-positive FAs and actin
stress fibers at 4 hours that were morphologically equivalent
to those formed when cells were plated on FNIII111, or
FNIII8v15, although the spreading parameters were always
best on intact FN (Figure 4a). At 24 hours, FN-null cells on all
surfaces continued to demonstrate good spreading, vinculin-
positive FAs, and actin stress fibers (Figure 4b). These cellular
attributes appeared essentially equivalent among cells plated
on GST-FNIII811, FNIII111, or FNIII8v15, although cells
plated on intact FN appeared to have more and larger FAs
than cells plated on the recombinant FN domains. By
48 hours, FN-null cells cultured on GST-FNIII811 were less
spread and demonstrated a loss of vinculin-positive FAs
compared to the other surface conditions (Figure 4c). By
72 hours, FN-null cells cultured on GST-FNIII811 had
become sparse. Although many microscopic fields of cultures
where FN-null cells had been plated on GST-FNIII811 for
72 hours had no cells, the field shown in Figure 4d was
selected for the presence of several cells. This was distinctly
unusual. The few cells remaining attached to GST-FNIII811-
coated plates were rounded and contained fragmented nuclei
(Figure 4d). Cells plated on intact FN, FNIII111, or FNIII8v15
continued to be mostly spread and have vinculin-positive FAs
and well-formed actin stress fibers at 72 hours. Given that
FN-null cells were well spread with good vinculin-positive
FAs and actin stress fibers for at least 24 hours on FNIII811,
the question arose as to whether a cellular abnormality could
be identified that preceded the loss of FAs and ability to
remain spread and attached to FNIII811-coated surfaces.
Fibroblasts undergo metabolic arrest, autophagy, and apoptosis
in the absence of FN-GFBDs
To understand better why FN-null cells died in the absence
of FN-GFBDs, cells were plated on GST-FNIII811 in the
presence or absence of exogenous PDGF-BB and assayed for
metabolic activity, autophagy, and apoptosis over a
72-hour time course. Although cell numbers at 24 hours
were nearly identical among FN-null cells cultured on plates
Table 1. KDs for PDGF-BB interactions with FN
domains derived from ka and kd
PDGF-BB PDGF-BB PDGF-BB EGF
ka (M1 s1) kd (s1) KD (nM)1 KD (nM)
FN70 NBB
2 NBB NBB NBB
rFNIII111
3 3.0 105 2.8 102 93 NBB
rFNIII17 5.1 105 4.2 102 82 NBB
rFNIII12 7.6 105 8.2 102 108 NBB
rFNIII1 3.5 105 3.6 102 103 NBB
FNIII211
4
(FN120)
NBB NBB NBB NBB
rFNIII36 NBB NBB NBB NBB
rFNIII811 NBB NBB NBB NBB
rFNIII12V15
5 8.0 105 2.3 102 29 NBB
rFNIII1215 4.5 105 1.2 102 27 NBB
rFNIII1214 5.6 105 2.7 102 48 NBB
rFNIII1314 4.5 104 4.1 104 9 NBB
rV5 2.9 105 4.1 102 141 NBB
Abbreviations: FN, fibronectin; rFNIII, recombinant fibronectin type III
repeat; ka, kinetic association constant; kd, kinetic dissociation constant;
KD, dissociation constant; PDGF-BB, platelet-derived growth factor-BB
1KD (nM) derived from surface plasmon resonance determinations.
2NBB, no binding observed as determined by surface plasmon resonance
determinations.
3rFNIII, recombinant FN domain produced as previously described (Wang
et al., 2005).
4FNIII211 by QStar pulsar I quadrupole time-of-flight mass spectroscopy
sequence identification of FN120 fragment.
5rFNIII12V15, recombinant FN domain in which the variable domain (V)
contains 120 residues.
PDGF-BB binding for FN and rFNIII8V15 could not be determined
secondary to high noise.
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precoated with GST- FNIII811 and those cultured on intact
FN, FNIII111, or FNIII8V15, cells cultured on GST-FNIII811
in the absence of exogenous PDGF demonstrated no rise in
metabolic activity at any time point, whereas cells cultured
on the other substrates did (Figure 5a). Although absolute
metabolic activity was increased in cells under all conditions
by the addition of PDGF-BB, FN-null cells on GST-FNIII811
still demonstrated relatively low metabolic activity com-
pared with other substrates. By 48 hours, the metabolism
of PDGF-treated FN-null cells on GST-FNIII811 was 30% of
PDGF-treated cells on intact FN. Although about one-third
of this metabolic reduction could be attributed to decreased
cell numbers (Figure 3a), the major deficiency could not. As
PDGF-BB-stimulated proliferation requires an initial signaling
event followed by a second signaling event 6–8 hours later
(Jones and Kazlauskas, 2001), 30 ngml–1 PDGF-BB was
added at 4 hours after plating and again at 10 hours after
plating to cells on GST-FNIII811. This maneuver, however,
did not correct the poor metabolic response to PDGF-BB, nor
improve FN-null cell survival (data not shown). Importantly,
cells plated on either FNIII111 or FNIII8V15 had essentially
the same metabolic activity as cells plated on FN, in the
absence and presence of exogenous PDGF-BB (Figure 5a).
As FN-null cells cultured on GST-FNIII811 lacked
metabolic activity in basal medium (DMEM) and had a poor
metabolic response to PDGF-BB, we examined whether
FN-null cells under these conditions developed signs of
increased autophagy, a homeostatic self-phagocytic process
that increases during times of cell stress such as nutrient or GF
deprivation (Gozuacik and Kimchi, 2007). In fact, FN-null
cells cultured on GST-FNIII811 showed signs of increased
autophagy by 4hours even in the presence of PDGF-BB, as
judged by ELISA assay of total cellular light chain 3 (LC3-I
plus LC3-II), a marker for autophagosome formation (Kabeya
et al., 2000; Jager et al., 2004) (Figure 5b). Total LC3 peaked
at 24 hours regardless of whether PDGF-BB had been added
at 4 hours. By comparison, cells plated on FN, FNIII111, or
FNIII8V15 showed much less accumulation of LC3 at
24 hours and significantly less accumulation at all time
points. The relatively low level of LC3 expression observed in
these latter conditions was expected as autophagy is a
physiological phenomenon that facilitates homeostatic pro-
cesses such as protein degradation and organelle turnover
(Gozuacik and Kimchi, 2007). Finally, western blots demon-
strated increased LC3-II, a cleaved LC3-I product that is
conjugated with phosphatidylethanolamine and bound to
phagolysomes (Kabeya et al., 2000, 2004), in cells on
FNIII811 at 24 hours (Figure 5c).
By 48 hours, substantial numbers of FN-null cells on
FNIII811 were undergoing apoptosis (29±3.2% without
PDGF, 22±2.5% with PDGF) (Figure 5d) as judged by the
TUNEL assay. Clearly, cells cultured on GST-tagged FNIII811
for 2 days or longer were refractory to exogenous PDGF-BB
rescue from apoptosis.
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Figure 3. Surface-bound intact fibronectin (FN) or FN-growth factor-binding domains (GFBDs), in contiguous arrays with the central cell-binding
domain (FNIII811), supported FN-null fibroblast survival and responsiveness to platelet-derived growth factor-BB (PDGF-BB). Mouse FN-null cells
were plated at 10,000 cells per well in 48-well tissue culture plates precoated (a) with 0.125 mM intact FN, FNIII111, FNIII8V15, or glutathione S-transferase
(GST)-tagged FNIII811; or (b) with intact FN, FNIII111, FNIII8V15, or GST-tagged FNIII811 at the concentrations indicated. Cells were first incubated in
DMEM for 4 hours and then with DMEM plus 1% BSA with or without 30 ngml–1 PDGF-BB at 37 1C. Viable spread cells in five  10 fields were visually
counted in each of the three replicate wells at the times shown (a) or at 3 days (b) for quantification of mean±SD (not shown for clarity but o10% of qmean,
n¼ 15). Approximately 200 cells per field were observed at 4 hours (baseline) in all conditions represented in a and b. All cells in all conditions were
well spread at 4 and 24hours. In panel b, the precoating concentration of 0.125 mM is denoted by the vertical dotted line. (c and d) FN-null cells were plated
as above in wells precoated with 0.125 mM intact FN or GST-tagged FNIII811, or with FN120 at the given concentrations (c), incubated in DMEM for 4 hours,
and then stimulated with PDGF-BB at 30 ngml–1 (c) or at the dose indicated (d) for 3 days at 37 1C. Cell viability in c was quantified as in a and b and
in d was determined by cell mitochondrial metabolism using the XTT assay. OD, optical density.
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FN-null cell survival required at least one FN-GFBD
To determine whether FN-null cell survival and response to
PDGF required contiguous FN-CCBD and -GFBDs, FN-null
cells were plated on plastic surfaces precoated with 0.125mM
GST-tagged FNIII811 with or without 0.125mM GST-tagged
FN-GFBDs. DMEM was changed 4 hours later to DMEM þ
1% BSA ± PDGF-BB and then incubated for up to 3 days.
FN-null cells survived in the presence of PDGF-BB when
cultured on GST-tagged FNIII811 with GST-tagged FN
domains with PDGF-BB-binding activity, i.e., FNIII17,
FNIII12, FNIII1, FNIII12V15, FNIII1215, or V, but did not
survive on FNIII811 alone or on FNIII811 and FNIII36, a
domain without PDGF-binding activity (Figure 6a). The
surface density of FNIII36 adsorbed to plastic dishes
was as high or higher than the FN-GFBDs as judged by
ELISA (data not shown). Therefore, the negative results
with FNIII36 were not attributable to poor surface adsorp-
tion. Hence, FN-null cell survival response to PDGF did
not require contiguous FN-CCBD and -GFBDs. However, in
the absence of PDGF-BB, FN-null cells on noncontiguous
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Figure 4. Fibronectin (FN)-null cells spread and formed focal contacts on FN-central cell-binding domain (FNIII811) similar to cells on intact FN or
contiguous arrays of FN-CCBD and FN-growth factor-binding domains (GFBDs) (FNIII111 or FNIII8v15) for at least 24 hours. FN-null fibroblasts were
cultured at 8,000 cells per 35-mm dish that had been precoated with 0.125 mM intact FN or glutathione S-transferase (GST)-tagged FNIII811, FNIII111, or
FNIII8v15 in DMEM for 4, 24, 48, or 72 hours at 37 1C. After the appropriate incubation times, cells were fixed, permeabilized, and stained for vinculin and
actin as described in Materials and Methods. (a) FN-null cells had formed vinculin-positive focal contacts (green) and actin stress fibers (red) on all
precoated surfaces by 4 hours. (b) Vinculin-positive focal contacts and actin stress fibers persisted in all cells at 24 hours. (c) By 48 hours, FN-null cells
plated on GST-FNIII811 were less well spread and had only a few vinculin-positive focal contacts, whereas cells on intact FN, FNIII111, or FNIII8v15
remained well spread with prominent actin stress fibers and many focal contacts. (d) By 72 hours, FN-null cells on dishes coated with GST-FNIII811 had
become sparse and those that remained were mostly rounded with minimal evidence of actin bundles or focal contacts, whereas cells on intact FN,
FNIII111, or FNIII8v15 continued to be spread with prominent actin stress fibers and focal contacts. Bar¼ 20mm.
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arrays of FN-CCBD (FNIII811) and FN-GFBDs did not
survive, although these cells had survived on contiguous
arrays of FN-CCBD and -GFBD (FNIII111 or FNIII8V15)
(Figure 3a). Importantly, differential response of FN-null
cells plated on different FN domains to exogenous
PDGF-BB was not secondary to differences in cell attach-
ment as judged by cell counts 4 hours after plating
(data not shown).
The findings above led us to investigate whether non-
contiguous arrays of FN-GFBDs with FNIII811 required
PDGF to prevent autophagy and apoptosis of FN-null cells.
FN-null cells on GST-FNIII811 alone, or on noncontiguous
arrays of GST-FNIII811 and GST-FNIII36, demonstrated
increased levels of the autophagy marker LC3 by 4 hours,
which increased further at 24 hours before returning to the
4-hour level by 48 hours, in the presence or absence of
exogenous PDGF-BB (Figure 6b, solid lines, closed circles,
and squares compared with open circles or squares,
respectively). In contrast, cells on noncontiguous arrays of
GST-GFBDs and GST-FNIII811 displayed little or no LC3
from 4 to 72 hours in the presence of exogenous PDGF-BB
(Figure 5c, dotted lines, closed symbols), although modest
increases in LC3 that peaked at 24 hours were observed in the
absence of PDGF-BB (Figure 6b, dotted lines, open symbols).
In concordance with the data in Figure 5b, cells on intact FN
showed basal levels of autophagy whether PDGF-BB was
present or not (Figure 6b, solid lines, closed-, and open
triangles, respectively).
FN-null cells on GST-FNIII811 alone demonstrated
increasing apoptosis over 3 days (30% at 3 days) (Figure
6c, solid line, open circles) and exogenous PDGF-BB weakly
protected against this (25% at 3 days) (Figure 6c, solid line,
closed circles). In the absence of PDGF-BB, FN-null cells on
noncontiguous arrays of GST-FNIII811 and GST-GFBDs
demonstrated less apoptosis (Figure 6c, dotted lines, open
circles, and triangles). More striking, however, was the
protection against apoptosis afforded to FN-null cells on
noncontiguous arrays of GST-FNIII811 and GST-GF-binding
domains with exogenous PDGF-BB (FNIII12, 15%;
FNIII1314, 14%, respectively, at 3 days) (Figure 6c, dotted
lines, closed circles, and triangles).
PDGF-BB preloaded on surface-bound FN-GFBD supported
FN-null fibroblast survival
PDGF-BB in media supported FN-null fibroblast survival on
GST-tagged FNIII811 and FN-GFBDs, i.e., FNIII17, FNIII12,
FNIII1, FNIII12V15, FNIII1215, or V, but not on FNIII811
alone, nor on FNIII811 and FNIII36, after culture for 3 days
(Figure 7a). Importantly, PDGF-BB also supported FN-null
fibroblast survival after culture for 3 days when preloaded on
FNIII811 and FN-GFBDs, but not when preincubated on
FNIII811 alone, nor on FNIII811 and FNIII36 (Figure 7b).
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Figure 5. Surface-bound fibronectin (FN)-growth factor-binding domains (GFBDs) contiguous with FN-central cell-binding domain (FNIII811) prevented
metabolic arrest, autophagy, and apoptosis of FN-null cells even in the absence of platelet-derived growth factor (PDGF). FN-null fibroblasts were
cultured at 4,000 cells per well in 96-well plates precoated with 0.125 mM intact FN or glutathione S-transferase (GST)-tagged FNIII811, FNIII111, or FNIII8v15
in DMEM for 4 hours, and then incubated with DMEM and 1% BSA with or without 30 ngml–1 PDGF-BB at 37 1C for times indicated. (a) Metabolic response
over 4 hours as judged by XTT assay. (b) Total cellular light chain 3 (LC3), a component of autophagosomes, was detected by rabbit polyclonal antibodies
using ELISA (Jager et al., 2004). (c) LC3-II, a translationally modified product of LC3 that binds to autophagosomes, was detected by a size shift on western
blot analysis using a polyclonal antibody specific for LC3 (Zhang et al., 2007). Alpha-actin was probed as a housekeeping protein in all gels and
showed no substantial difference among samples within a given gel. (d) Apoptosis was determined by the TUNEL assay for fragmented DNA manifested
by bright yellow fluorescent spots on a background of red 40,6-diamidino-2-phenylindole-stained nuclei. Percent apoptosis was determined by counting
those cells positive for DNA fragmentation, dividing by total cell number, and multiplying by 100. Fifty cells were counted in each of three replicate
plates. Data points indicate mean±SD. In panels a and b, each data point was performed in quadruplicate and each panel is representative of at least
three different experiments. The western blot in panel c is representative of two different experiments. OD, optical density.
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Intact FN and FN-GFBDs must be surface-bound to support
FN-null cell survival and to promote PDGF-BB responsiveness
To determine whether FN-GFBD activity required their
presence on a surface, we investigated whether intact FN or
recombinant FN-GFBDs that were contiguous with the
FN-CCBD (FNIII111 or FNIII8v15) could support FN-null
cell survival and/or promote PDGF-BB responsiveness
when added to cultures in solution (DMEM). At 4 hours
after FN-null cells had been plated on GST-FNIII811-coated
wells, cells were treated with intact FN, FNIII111, or
FNIII8v15 in DMEM with or without 30 mgml
–1 PDGF-BB.
All these conditions failed to promote survival of FN-null
cells cultured on FNIII811 for 3 days (Figure 8a). As controls,
FN-null cells were plated on intact FN, FNIII111, or
FNIII8v15 and 4 hours later exposed to exogenous PDGF-
BB in DMEM or fresh DMEM alone. FN-null cells survived
on these surfaces without PDGF-BB and proliferated in its
presence (Figure 8a) in concert with results shown in
Figure 3a and b. Likewise, shorter recombinant GST-GFBDs
added in DMEM (solution) with or without PDGF-BB failed
to promote FN-null cell survival on FNIII811 for 3 days
(Figure 8b).
Next, we investigated whether FN-GFBDs on the surface
of beads added to culture medium could support the viability
of FN-null cells plated on FNIII811. For these experiments,
0.125mM cys-tagged FNIII12 or FNIII1215 with or without
cys-tagged FNIII811 were linked to agarose beads as
described in Materials and Methods. Surprisingly, bead-bound
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Figure 6. Surface-bound fibronectin (FN)-growth factor-binding domains
(GFBDs) in noncontiguous arrays with the FN-central cell-binding domain
(FNIII811) supported FN-null fibroblast responsiveness to platelet-derived
growth factor-BB (PDGF-BB). FN-null fibroblasts were cultured at 4,000 cells
per well in 96-well plates precoated with 0.125 mM intact FN or glutathione
S-transferase (GST)-tagged FN domains in DMEM for 4 hours, and then
incubated with DMEM and 1% BSA with or without 30 ngml–1 PDGF-BB
at 37 1C for times indicated. (a) Survival as judged by the XTT assay.
(b) Autophagy as judged by ELISA for light chain 3 (LC3). (c) Apoptosis as
determined by the TUNEL assay. Percent apoptosis was determined by
counting those cells positive for DNA fragmentation, dividing by total cell
number, and multiplying by 100. Fifty cells were counted in three replicate
plates. Data points indicate mean±SD. The data shown in each of these
panels are representative of at least three different experiments. All
recombinant FN domains were GST-tagged but the prefix is omitted here for
brevity. OD, optical density.
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Figure 7. Surface-bound fibronectin (FN)-growth factor-binding domains
(GFBDs) supported FN-null fibroblast responsiveness to platelet-derived
growth factor-BB (PDGF-BB) whether the PDGF-BB was present in the
medium or preloaded on the FN-GFBD. FN-null fibroblasts were cultured
at 4,000 cells per well in 96-well plates precoated with 0.125 mM intact FN
or glutathione S-transferase (GST)-tagged FN domains in DMEM for 4 hours,
and then incubated in DMEM at 37 1C for 3 days under the following
conditions. (a) PDGF-BB was present in the medium during 3-day
culture and then cells were counted. (b) PDGF-BB was preloaded on
FN domain-coated dishes for 2 hours, washed 10 times, cells cultured as
above, and then counted. Cells in three  10 fields were counted in each
of the four wells (mean±SD, n¼12).
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recombinant FN-GFBDs, in the presence or absence of
FNIII811, failed to promote FN-null cell viability, despite the
fact that the same FN-GFDBs when used with FNIII811
to precoat plates did support cell viability (Figure 8c).
It was possible, however, that insufficient numbers of cell
surface receptors for the FN-CCBD (FNIII811) were
available on the upper surface of cells plated on FNIII811,
i.e., all such receptors may have already been ligated to
FNIII811 on the plates. To examine whether this possibility
was correct, FN-null cells were plated in tissue culture wells
precoated with type I collagen and then incubated in the
presence of PDGF with or without microbeads coated with
either FNIII811 alone, GFBDs (FNIII12 or FNIII1215) alone,
or the combination of FNIII811 plus either FNIII12 or
FNIII1215 (Figure 8d). When FNIII811 and FN-GFBDs (either
FNIII12 or FNIII1215) were present on the same bead, FN-
null cell viability was sustained in the presence of exogenous
PDGF-BB. If beads were precoated with only one domain,
cells died even in the presence of PDGF-BB. Importantly, FN-
null cells also failed to survive on collagen if two sets of
beads, one set precoated with FNIII811 and another set
precoated with either FNIII12 or FNIII1215, were added to
cells simultaneously (Figure 8d). Given the data in Figure 8d,
it was not surprising that FN-null cells cultured on plates
precoated with type I collagen failed to survive when
FNIII811 and GFBDs (either FNIII12 or FNIII1215) in
solution were added to the culture medium either individu-
ally or together (Figure 8e). These findings were not simply
secondary to fluid-phase FN or FN-GFBDs inhibiting
exogenous PDGF-BB activity on cultured cells, as FN-null
cells plated on surface-bound intact FN responded similarly
to PDGF-BB whether or not FN or FN-GFBDs were present in
the medium until supraphysiological concentrations of intact
FN were used (Figure 8f).
DISCUSSION
Here, for the first time, FN domains flanking the CCBD were
found to bind PDGF-BB with KDs between 10 and 100nM.
Together, the FN-CCBD and FN-GFBDs were demonstrated
to be necessary and sufficient for FN-null cell survival, and
when contiguous, also necessary and sufficient for FN-null
cell proliferation. Furthermore, cell survival activity required
that FN-CCBD and FN-GFBDs be in proximity on the same
surface.
Figure 8. Fibronectin (FN)-null fibroblast response to platelet-derived growth factor-BB (PDGF-BB) required surface-bound FN or FN-growth factor-binding
domains (GFBDs). (a) FN-null fibroblasts were cultured at 10,000 cells per well in 48-well tissue culture plates precoated with 0.125 mM of intact FN or
glutathione S-transferase (GST)-tagged fibronectin type III repeats (FNIII811), FNIII111, or FNIII8V15, in DMEM for 4 hours, and then incubated in DMEM along
with 1% BSA with or without 30 ngml–1 PDGF-BB ±0.125 mM intact FN or FN domains in solution as indicated at 37 1C for 3 days. Cells in five  10 fields
were visually counted in each of the three wells at times indicated for mean±SD (n¼15). (b) FN-null fibroblasts were cultured at 4,000 cells per well in
96-well plates precoated with 0.125 mM intact FN or GST-FNIII811 in DMEM for 4 hours, and then incubated with DMEM and 1% BSA with or without
30 ngml–1 PDGF-BB ±0.125 mM GST-tagged FN domains in solution as indicated at 37 1C for 3 days. Cells were counted as described above. (c) FN-null
cells were cultured at 4,000 cells per well in 96-well plates precoated with 0.125 mM intact FN or GST-FNIII811. Media were changed at 4 hours to DMEM
and 1% BSA with or without 30 ngml–1 PDGF-BB ±0.125 mM GST-tagged FN domains on microbeads as indicated, and then cultures were incubated at
37 1C for 3 days. Viability was measured by the XTT assay. (d) FN-null cells were cultured at 4,000 cells per well in 96-well plates precoated with 0.125 mM
intact FN or type I collagen. Media were changed at 4 hours to DMEM and 1% BSA with or without 30 ngml–1 PDGF-BB±0.125 mM GST-tagged FN domains
on microbeads as indicated, and then cultures were incubated at 37 1C for 3 days. Viability was measured by the XTT assay. (e) FN-null cells were
cultured at 4,000 cells per well in 96-well plates precoated with 0.125 mM intact FN or type I collagen. Media were changed at 4 hours to DMEM and
1% BSA with or without 30 ngml–1 PDGF-BB ±0.125 mM GST-tagged FN domains in solution as indicated, then cultures were incubated at 37 1C for
3 days. Viability was measured by the XTT assay. (f) FN-null fibroblasts were cultured at 4,000 cells per well in 96-well plates precoated with 0.125 mM
intact FN in DMEM for 4 hours and then incubated with DMEM and 1% BSA with or without intact FN, GST-FNIII12, or GST-FNIII36 in solution at the
concentrations indicated with or without 30 ngml–1 PDGF-BB at 37 1C for 3 days. Viability was measured by XTT assay. SD are not shown here for clarity,
but were o10% of mean (n¼ 4). Open bars¼DMEM alone. Closed bars¼DMEM plus 30 ngml–1 PDGF-BB. OD, optical density.
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FN and fibroblast survival
Previous studies have demonstrated that for survival some
mesenchymal cells, e.g., Chinese Hamster Ovary cells,
require integrin a5b1 binding to FN (Zhang et al., 1995),
and by extrapolation, ligation of the Pro–His–Ser–Arg–Asn and
RGD-binding sites within the ninth and tenth type III repeats
of FN, respectively (Pankov and Yamada, 2002). Thus, it was
initially surprising that the FN-CCBD (FNIII811) did not
support FN-null cell survival. Even more surprising was
the observation that exogenous PDGF-BB could not rescue
FN-null cells cultured on FNIII811 from apoptosis, as PDGF-
BB is known to be an important survival factor for fibroblasts
(Franke et al., 1997; Romashkova and Makarov, 1999). That
FN-null cell survival and responsiveness to exogenous PDGF
required surface-bound FN-GFBDs suggested that an intimate
interaction of FN and PDGF-BB with the appropriate
fibroblast surface receptors may be requisite for the genera-
tion of appropriate survival signals (Figure 9).
Although it is known that integrins and GFs can be
costimulatory for fibroblasts (Plopper et al., 1995; Miyamoto
et al., 1996), it has not been previously reported that
fibroblast survival requires a coordinate interaction of FN
and PDGF-BB, or other GFs. On further consideration, the
fact that mesenchymal cell survival requires coordinate
interaction of FN with integrins and PDGF-BB with PDGF
receptors in proximity is not dissimilar to the concept of
T-cell multidimensional signaling network stimulation
through the immunological synapse and costimulatory
pairs in the same nanospace (Tseng and Dustin, 2002). As
signal transduction pathways are often under strict, solid-state
control inside the cell (Saltiel and Pessin, 2002), initiators of
signaling outside the cell may be under the same kind of
spatial control, rather than the result of simple diffusion.
Future studies, using immunocytological techniques, such as
fluorescence resonance energy transfer analysis, are needed
to determine whether the proximity of FN-CCBD and its
ligand a5b1 with PDGD-b receptors and its ligand PDGF-BB
is at the nanospace level.
The data presented here clearly demonstrate that FN-
GFBDs, in addition to the FN-CCBD (Renshaw et al., 1997),
were required for FN-null cell survival. Nevertheless, FN-null
cells plated on FNIII811 could and did respond to exogenous
PDGF-BB, although suboptimally, as demonstrated by
increased metabolism and decreased autophagy. In preli-
minary studies not shown in this paper, PDGF-b receptor
was hypophosphorylated in response to PDGF-BB when
FN-null cells were cultured on FN-CCBD (FNIII811) without
FN-GFBDs. The dependence on FN-GFBD for FN-null
cell survival or PDGF-BB responsiveness was further con-
strained by the requirement of the FN-GFBDs to be surface
bound.
Although FN-GFBDs in noncontiguous arrays with
FNIII811 required exogenous PDGF-BB for their prosurvival
activity, contiguous arrays of FNIII811 and FN-GFBDs did
not require the presence of PDGF-BB to promote survival. In
the latter situation, however, PDGF-BB induced a growth
response, whereas in the former situation it did not. These
differential levels of PDGF-BB responsiveness were not
simply a manifestation of the need for two distinct phases
of PDGF-BB signaling (Jones and Kazlauskas, 2001), as
30 ngml–1 PDGF-BB added at 4 and 10 hours to cells on
FNIII811 did not correct the poor metabolic response to
PDGF-BB nor improve FN-null cell survival. Thus, FN-null
cell responsiveness to PDGF-BB was a gradient function of
surface-bound FN domains (FNIII811 o noncontiguous
arrays of FNIII811 and FN-GFBDs o contiguous arrays of
FNIII811 and FN-GFBDs). Exogenous PDGF-BB could
partially protect FN-null cells plated on the FN-CCBD
(FNIII811) against cytolysis and autophagy and promote a
weak metabolic response; however, these cells eventually
underwent apoptosis. When FN-null cells were cultured on
noncontiguous arrays of FNIII811 and FN-GFBDs, exogen-
ous PDGF-BB had a greater protective affect against cytolysis
and autophagy, and promoted a stronger metabolic response.
More importantly, and perhaps as a consequence, FN-null
cells on noncontiguous arrays of FNIII811 and FN-GFBDs
1 2
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Figure 9. Proposed mesenchymal cell-extracellular matrix (ECM) synapse. Transmembrane a5b1 integrin binds to the fibronectin (FN) central cell-binding
domain (fibronectin type III repeats (FNIII811) and is flanked by a platelet-derived growth factor (PDGF) receptor and a putative growth factor x receptor
(GFxR), which are binding their respective ligands that in turn are bound to two of the GF-binding sites of FN, herein indicated arbitrarily by the
carboxy-terminal portion of FNIII1 and FNIII13. PDGF-BB, platelet-derived growth factor-BB; PDGFR, platelet-derived growth factor receptor.
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responded to PDGF-BB with increased survival and de-
creased apoptosis. Finally, when FN-null cells were cultured
on intact FN or on contiguous arrays of FNIII811 and
FN-GFBDs, they survived without PDGF-BB and proliferated
in its presence. These findings suggested that there are
either GF-independent survival sequences within the
larger recombinant FN polypeptides, or perhaps loading of
minute, but strategically localized, amounts of endogenous
PDGF can occur on contiguous arrays of FN cell- and
GF-binding domains, but not on noncontiguous arrays of
these domains.
FN and fibroblast FA formations
Previous studies have indicated that the FN-CCBD is
insufficient for FA formation and that the major heparin-
binding domain (HepII) facilitates FA formation (Woods
et al., 1986; Morgan et al., 2007) in a RhoA-dependent manner
(Ridley and Hall, 1992; Ren et al., 1999). More recently,
however, we demonstrated that the HepII requirement for FA
formation can be overcome by increased surface density of the
CCBD (FNIII811) (Wang et al., 2005). This was accomplished
by GST-tagging FNIII811, which greatly improved surface
adsorption of the recombinant protein. When plated on
GST-FNIII811, both normal human dermal fibroblasts and
FN-null cells attached, spread, and formed FA, in a manner
indistinguishable from cells plated on intact human plasma FN,
for up to 2hours (Wang et al., 2005). Here, we have expanded
these observations to 3 days. At 4hours, FN-null cells
formed FA on GST-FNIII811 that continued to be indistinguish-
able from cells plated on intact human plasma FN. At 24hours,
the FA formation on GST-FNIII811 was clearly evident,
although less robust than on intact FN. FA formation on
recombinant FNIII111 and FNIII8v15, which included the
FN-GFBDs, appeared similar to FA formation on GST-FNIII811
alone. However, by 48hours, the FN-null cell FA formation
on GST-FNIII811 had dissipated, whereas FA in FN-null
cells plated on intact FN, or on either recombinant FNIII111
or FNIII8v15, were sustained. This should not be surprising
as FA depends on the activation of RhoA (Wang et al.,
2005), which, unlike Rac1 and Cdc42, is exquisitely sensitive
to GTP and ATP depletion (Hallett et al., 2003), and FN-null
cells cultured on GST-FNIII811 demonstrated a metabolic
block.
FN and fibroblast metabolism and autophagy
Cells require a constant supply of oxidizable nutrients for
survival. Cells in multicellular organisms meet this need
through two fundamental mechanisms (Lum et al., 2005).
GF stimulation induces uptake of glucose and amino acids
to support ATP generation and biosynthesis. If this fails,
cells lower their biosynthetic demand, but still need sufficient
nutrients to support basic functions such as adhesion and
survival. To sustain themselves such cells begin to degrade
intracellular molecules. An extreme form of this catabolic
degradation is autophagy, a process in which cells sequester
macromolecules and cell organelles into acidic vacuoles for
bulk digestion. These vacuoles, or autophagolysosomes,
arise from the entrapment of cell components within
a double-membrane structure that forms around them
and then fuses with lysosomes. The molecular processes
involved in autophagolysosome formation are evolutionarily
conserved from yeast to man, and require an orchestrated
recruitment of specific proteins and lipoproteins to the
double membrane as it expands and engulfs cell constituents
(Xie and Klionsky, 2007). If autophagy fails to satisfy
the cell’s need for nutrients, then autophagy can segue
to apoptosis (Yoshimori, 2007). This is the first report
to demonstrate that surface-bound FN was required for
GF-stimulated metabolism. Furthermore, this activity was
attributable to FN-GFBDs that prevent induction of autop-
hagy and subsequent apoptosis.
Multiple FN-GFBDs
Given the apparent importance of FN-GFBDs to fibroblast
survival, it is reasonable that multiple FN-GFBDs might exist.
However, the possibility of redundant binding sites raises the
questions of their explicit molecular localization and of
possible similarities in their sequence pattern. If fact, using
bioinformatics screening techniques to search for such patterns,
we have discovered two peptides within FNIII1, one peptide
within FNIII13, and one peptide within V that have similar
sequence patterns and binds PDGF-BB with similar KD as their
parent domains. The complete elucidation of these sites, their
PDGF-BB-binding activities, and their bioactivities are the
current focus of our laboratory.
GF binding to FN and other ECM molecules
PDGF-BB is one of an expanding number of GFs that
are bound and retained by FN, either directly or indirectly.
GFs that directly bind FN include VEGF (Wijelath et al.,
2002, 2004, 2006), hepatocyte growth factor (Rahman et al.,
2005), tumor necrosis factor-a (Alon et al., 1994), and
connective tissue growth factor (Yoshida and Munakata,
2007). Those that bind indirectly include IGF via IGF-binding
proteins (Gui and Murphy, 2001), and transforming
growth factor-b via latent transforming growth factor-b-
binding protein-1 (Dallas et al., 2005). As FN is a key
component of the provisional matrix of wounds (Welch et al.,
1990), its ability to bind and localize GFs helps it to serve as a
vital modulator of biological activity during repair and
regeneration. Although these previous studies have shown
that GFs bound to FN retain activity, GF–FN interactions have
not previously been demonstrated to be required for cell
survival.
GFs also can bind to ECM molecules other than FN, as
previously reviewed (Macri et al., 2007). Fibrin(ogen),
heparan sulfate, decorin, FN, and vitronectin are just a few
of the many molecules located in the provisional matrix and/
or ECM that can bind and modulate the activity of various
GFs. However, binding of any of these GFs to ECM molecules
has not been previously shown to be essential for cell survival
(Macri et al., 2007).
Conclusion
Here, we demonstrated for the first time that FN-GFBDs were
critical for fibroblast survival and were required for fibroblast
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proliferative response to PDGF-BB. Furthermore, we found
that the FN-CCBD (FNIII811) and FN-GFBDs must be affixed
to the same surface to promote cell survival in the presence of
exogenous PDGF-BB. That cell survival and responsiveness
to PDGF required surface-bound FN-GFBD in proximity to
the FN-CCBD suggested that an intimate interaction of FN
and PDGF-BB with the appropriate cell surface receptors may
be requisite for the generation of appropriate survival signals
(Figure 9). In fact, the absence of FN in nonhealing chronic
wounds and burns (Grinnell and Zhu, 1994; Herrick et al.,
1996) may be the reason why they fail to heal and/or
demonstrate progressive tissue destruction, respectively.
Although FN itself is exquisitely sensitive to proteolytic
digestion, its functional domains are relatively resistant to
such degradation (Yamada and Clark, 1996; Pankov and
Yamada, 2002). Thus, a tissue-engineered construct com-
posed of FN domains that are necessary and sufficient for
fibroblast survival and growth and a relatively proteolytically
resistant matrix to which they are tethered may be of great
benefit for chronic nonhealing wounds, acute wounds that
are too large to close, or extensive burns (Clark, 2008b). In
addition, these finding are important to our further under-
standing of cell–matrix interactions, i.e., perhaps FN signal-
ing, apart from that generated directly by integrin receptor
binding, is mediated indirectly through its ability to localize
GFs to the matrix and trigger GF-mediated signaling
concurrently.
MATERIALS AND METHODS
Materials
Recombinant PDGF-BB was obtained from Biosource (Camarillo,
CA), and 125I-PDGF-BB from Amersham Biosciences (Piscataway,
NJ). Human plasma FN, purchased from Chemicon (Temecula, CA),
was 99% pure and intact as determined by SDS-PAGE. FN fragment
(70 kDa) and DMEM was obtained from Sigma (St Louis, MO).
SulfoLink coupling gel was acquired from Pierce. Fatty acid-free BSA
was purchased from ICN Biomedicals (Aurora, OH). Ni-NTA
agarose beads were acquired from Qiagen (Valencia, CA).
Isopropyl-beta-D-thiogalactopyranoside and L-broth were purchased
from Fisher Scientific (Fair Lawn, NJ) and fetal bovine serum from
Hyclone (Logan, UT). Culture plates were from BD Bioscience
(Billerica, MA). Cell Proliferation kit II (XTT) and In Situ Cell
Death Detection kit (TUNEL reaction mixture) were from Roche
Diagnostics (Indianapolis, IN). The BIAcore 2000, CM5 sensor chips,
N-hydroxysuccinimide, N-ethyl-N 0-(3-diethylaminopropyl)carbodiimide
hydrochloride, and 1M ethanolamine (pH 8.5) were purchased from
BIAcore (Piscataway, NJ). Surface plasmon resonance experiments
were performed using a BIAcore 2000 at the University Proteomics
Center at Stony Brook University. Mouse monoclonal anti-vinculin
antibody (V9131) was purchased from Sigma. Oregon Green 488
goat anti-mouse IgG(Hþ L) (O11033), Alexa Fluor 488 phalloidin,
and 40,6-diamidino-2-phenylindole were acquired from Molecular
Probes, Invitrogen (Carlsbad, CA).
Expression and purification of FN functional domains
Methods for cloning, expression, and purification of recombinant
human FN domains and fusion products of FN domains with
GST were previously published (Wang et al., 2005). A GST tag
on the amino-terminus of the recombinant proteins facilitated
FN domain adsorption onto tissue culture plastic for cell function
studies. We also previously described cloning, expression, and
purification of cys-tagged FN domains (Ghosh et al., 2006).
Cys-tagged FN domains allowed linkage to SulfoLink agarose
beads with minimal impact on protein conformation. Briefly, FN
domains were generated by PCR using the human cDNA
clones pFH1, pFH111, and pFH154 (ATCC) as templates or by
subcloning the restriction enzyme fragments from each of
the aforesaid plasmids. FN domains were cloned in pETCH, a
modified pCal-n vector (Stratagene, La Jolla, CA), with a carboxy-
terminal six-histidine affinity tag with or without a carboxy-terminal
cysteine, and with or without a amino-terminal GST tag. The inserts
were cloned at the BamHI and HindIII sites, and confirmed by
DNA sequencing to rule out possible synthesis errors during PCR.
Protein expression was induced in the BL21DE3LysS strain of E. coli
by the addition of 0.5mM isopropyl-beta-D-thiogalactopyranoside
and affinity purified using Ni-NTA agarose beads. After elution with
a buffer containing 300mM imidazole and 200mM NaCl, the
proteins were desalted by passing over a Sephadex G25 column
(Amersham Pharmacia Biotech AB, Uppsala, Sweden) in the
presence of phosphate buffered saline (PBS). In recombinant
constructs that contained the FN variable domain, all 120 residues
were included (V120).
Equilibrium binding of PDGF-BB with FN or FN domains
FN domains were conjugated to agarose beads via –SH groups
according to the manufacturer’s protocol (SulfoLink Coupling Gel;
Pierce). To block nonspecific binding, agarose beads conjugated
with or without FN or FN domains were incubated with 2% BSA
at room temperature for 2 hours. For equilibrium binding, 20 ml
of conjugated-agarose beads were incubated with varying concen-
trations of 125I-labeled PDGF-BB in 100ml of binding buffer
(DMEMþ 1% BSA) at room temperature for 2 hours with rotation.
The beads were then washed six times with PBS, and the
radioactivity bound to the agarose beads was quantified using a
g-counter. The binding constant of PDGF-BB with FN or FN domains
was determined using Prism 4 nonlinear regression software
(GraphPad, San Diego, CA).
Immobilization of PDGF-BB on sensor chips
PDGF-BB was coupled to CM5 sensor chip surfaces using a standard
amine coupling procedure and a flow rate set at 5ml minute–1.
Sequential injections consisted of a 0.05M N-hydroxysuccinimide
and 0.2 M N-ethyl-N 0-(3-diethylaminopropyl) carbodiimide
hydrochloride mixture (10ml), followed by PDGF-BB (10 mgml–1)
in 10mM acetic acid (pH 4.0) until the desired amount of
coupled PDGF was reached. A solution of 0.1 M ethanolamine
HCl (35 ml, pH 8.5) was then used to block the remaining
activated carboxyl groups. Dextran-coated chips were used as
controls.
Kinetic binding assay of PDGF-BB with FN domains
In the BIAcore 2000 system, plasmon resonance system determines
real-time protein–protein interaction allowing determination of koff
and kon, the ratio of which is KD. The kinetic binding constants were
determined by passing varying concentrations of FN functional
domains (analytes) dissolved in 20mM Hepes, 150mM NaCl, 3.4mM
www.jidonline.org 95
F Lin et al.
FN-GFBDs for Fibroblast Survival
EDTA, and 0.05% Tween-20, pH 7.4, over chip surfaces that had
been coupled with PDGF. All kinetic experiments were carried out
at 20 1C at a flow rate of 30 ml minute–1. For mass transport
experiments, each analyte was injected at a fixed concentration
and run at flow rates ranging from 5 to 75 mlminute–1. All analytes
were injected over a PDGF-coupled surface, as well as over a
control surface for 120 seconds, followed by 300 seconds of
dissociation in running buffer. Regeneration of the sensor chip for
subsequent injections was accomplished by one pulse of 0.05% SDS
(30 seconds).
Data preparation and analysis for kinetic binding assay
Sensorgrams were prepared and globally fit using nonlinear least-
squares analysis and numerical integration of the differential rate
equations using the BIAcore manual. Briefly, each sensorgram
generated using a control surface was subtracted from the
corresponding experimental sensorgram, and the resulting curves
were transformed to concentration units using the molecular mass
of the injected species, the equivalence of 1,000 resonance units
per 1 ngmm–2, and a matrix thickness of 100 nm. Each data set,
which consisted of a series of sensorgrams from injections of
different concentrations of analyte over the same surface type,
was then analyzed using kinetic models that are available in
the BIAevaluation software (GE Healthcare Bio-Science Biacore,
Piscataway, NJ).
Cell culture
Generation of mouse FN-null fibroblasts was described previously
(Saoncella et al., 1999). The cells were maintained in DMEM
supplemented with 100Uml–1 penicillin, 100mgml–1 streptomycin,
and 10% fetal bovine serum at 37 1C and 5% CO2/95% air in a
humidified atmosphere. For the cell functional assays, the FN-null
cells were grown to B80% confluence, harvested, and centrifuged
to obtain a pellet that was rinsed once with DMEM. After
resuspension in DMEM, cells were counted and transferred to tissue
culture plates in the appropriate numbers for a given assay.
Cell survival assays
Cell survival experiments were carried out on 48- or 96-well plates
that had been coated with 0.125 mM of FN, other ECM protein, or FN
domains in PBS overnight at room temperature (Wang et al., 2005).
After blocking with 2% BSA for 2 hours at room temperature to
exclude further protein binding, the plates were washed three times
with PBS. For each 48- or 96- well plate, 10,000 or 4,000 FN-null
cells per well, respectively, were seeded in DMEM and incubated at
37 1C for 4 hours. Then, BSA to a final concentration of 1% was
added to each well, with or without PDGF-BB or FN domains, and
the wells were incubated for varying time periods. Cell survival was
measured by counting cells and by determining cell mitochondrial
metabolism using the XTT assay (Roche Diagnostics).
FN-null cell endogenous PDGF
To establish whether FN-null cells were producing and secreting
appreciable amounts of either PDGF-AA or PDGF-BB, the levels of
these GFs were determined in FN-null cell lysates and in cell culture
medium by ELISA using anti-mouse PDGF-AA and anti-mouse
PDGF-BB antibodies (Santa Cruz Biotechnology, Santa Cruz, CA).
The detection limits for both PDGF-AA and PDGF-BB was
0.1 ngml–1. To determine cellular PDGF-AA and PDGF-BB,
1 106 cells per ml FN-null cells were dissolved in lysis buffer
containing 1% Triton X-100, 0.1% SDS, 1% BSA, and protei-
nase inhibitors. After removing particulates by centrifugation,
supernatants were tested by ELISA. Results showed that lysates of
cells, which had been incubated in serum-free DMEM for 48 hours,
contained 0.34 ng per 106 cells of PDGF-AA and 0.28 ng per 106
cells of PDGF-BB. Negligible PDGF-AA and PDGF-BB had
accumulated in the culture medium during this time period.
TUNEL assay
Apoptotic cells were identified by nick-end labeling using In Situ
Cell Death Detection kit and TMR red as per the manufacturer’s
protocol. Briefly, eight-well cell culture chambers were coated with
0.125mM of FN or FN domains in PBS overnight at room
temperature. The chambers were then blocked with 2% BSA for
2 hours, followed by a triple wash with PBS. For each well, 8,000
FN-null cells were seeded in DMEM and incubated at 37 1C for
4 hours, followed by the addition of BSA to a final concentration of
1% in the presence or absence of 30 ngml–1 PDGF-BB, unless
otherwise stated. At the end of the various incubations, cells were
fixed with 4% paraformaldehyde, permeabilized with 0.1% Triton
X-100, probed with TUNEL reaction mixture, and cell nuclei were
counterstained with 40,6-diamidino-2-phenylindole. Specimens
were imaged in PBS with a  20, aperture 0.4 objective on an
inverted Diaphot-TMD Nikon (Nikon, Melville, NY) fluorescent
microscope using a CCD camera and Metamorph software
(Molecular Devices, MDS Analytical Technologies, Sunnyvale, CA).
Analysis of the autophagosome protein LC3
The assay for total LC3 followed the manufacturer’s protocol for
Cellular Activation of Signaling ELISA (CASE) kits from Superarray
(Fredrick, MD). All reagents were from the Superarray CASE kit
except the polyclonal anti-LC3 antibody, which was purchased from
Santa Cruz Biotechnology.
For western blots of LC3I and LC3II, cells were harvested
and homogenized in 10mM Tris buffer, pH 8.0, containing 1% Triton
X-100, 0.1% SDS, 140mM NaCl,1% sodium acetate, 10 mgml–1
leupeptin, 10 mgml–1 aprotinin, and 0.1mM phenylmethylsulfonyl
fluoride. Nuclei were removed by low-speed centrifugation.
Post-nuclear fraction protein/lane (10 mg) was subjected to 15%
SDS-PAGE. Separated proteins were transferred onto nitrocellulose
membrane, blocked with 5% (w/v) dry milk, and incubated with
primary polyclonal antibodies specific for LC3 (Novus Biologicals,
Littleton, CO) overnight at 4 1C. After washing, the blots were
incubated with a secondary anti-rabbit IgG antibody labeled with
peroxidase. The blots were developed by chemiluminescence and
images were collected using Chemiimager 4400 system (Imgen
Technologies, Alexandria, VA).
Cell staining and imaging
Eight 35-mm-well plate (Becton Dickinson, Franklin Lakes, NJ)
surfaces were precoated using 0.125 mM FN or FN domains,
maintained overnight at room temperature, and then blocked using
2% (w/v) BSA at room temperature for 2 hours. Each well was rinsed
three times with PBS, and then FN-null fibroblasts were seeded at
40,000 cells per ml (8,000 cells in 200ml serum-free DMEM for each
well), and incubated at 37 1C. After 4, 24, 48, or 72 hours incubation
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time periods, cells were fixed with 4% paraformaldehyde in PBS
for 15minutes, permeabilized with 0.4% Triton X-100 in PBS
for 5minutes, and blocked with 2% BSA in PBS for 30minutes at
room temperature. FAs were stained at room temperature with
anti-vinculin antibody for 1 hour, followed by Oregan Green 488
goat anti-mouse IgG for 1 hour. Actin was counterstained with Alexa
Fluor 546 phalloidin. After washing, cells in residual PBS were
immediately overlaid with a coverslip and imaged for fluorescence
with a  40, aperture 0.9, oil objective on a Leica TCS SP2 laser
scanning confocal microscope (Leica Microsystems, Wetzlar,
Germany). All images were recorded with a CCD camera using
the same resolution (1024 1024 pixel).
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